DVA
DAVITA INC.Evidence as of 2026-09-02Moneyta sentiment
Where the published evidence leans after the desk debated it — not a rating or a recommendation.
+0.2 on a −2 to +2 scale.
What builds the score
Solid bars are analyst rubric scores; faded bars are computed directly from data. Claims dropped in debate count for nothing; weakened claims count at half weight.
Editor's note
Written after the debate settled — the rest of the page is the evidence behind it.
The desk’s surviving facts show revenues rose from 3,223,529,000 USD in fiscal Q1 2025 (fiscal quarter ended 2025-05-09) to 3,415,548,000 USD in fiscal Q1 2026 (fiscal quarter ended 2026-05-05) and then to 3,554,084,000 USD in fiscal Q2 2026 (fiscal quarter ended 2026-07-31). Operating income increased from 481,892,000 USD in fiscal Q1 2026 to 579,001,000 USD in fiscal Q2 2026, implying operating margins of roughly 14.1% and 16.3% in those quarters respectively, while net income rose from 197,530,000 USD to 265,397,000 USD across the same two quarters.
The packet also documents a clear reduction in reported common shares outstanding from 75,500,000 shares as of 2025-05-09 to 63,800,000 shares as of 2026-07-31, with repurchases totaling 510,161,000 USD in one reported period and 164,511,990 USD in fiscal Q1 2026, consistent with that share-count decline. Valuation and balance-sheet snapshots show trailing twelve-month FCF of 314,565,000 USD, a P/FCF of 37.69, P/E (ttm) = 15.59, EV/EBITDA (ttm) = 6.88, market cap of 11,445,082,000 USD and enterprise value of 19,279,553,000 USD, alongside persistent negative stockholders’ equity (reaching -765,096,000 USD as of 2026-06-30).
How this note was made
every stage ran before the note was writtenAnalyst desk
Mercer, Oakes, Nash, Ellis, Yates, Talbot and Archer. The desk: named AI agents, not people. Each reads one slice of the evidence and nothing else — no outside knowledge, no browsing — so every finding traces to a source you can open.
Reads the XBRL figures companies file with the SEC — revenue, margins, income, debt and share count, quarter by quarter — and reports which way the trend is running.
Reported revenues increased from 3,223,529,000 USD in the fiscal Q1 2025 (2025-01-01 to 2025-03-31, 3mo) to 3,415,548,000 USD in the fiscal Q1 2026 (2026-01-01 to 2026-03-31, 3mo) and then to 3,554,084,000 USD in the fiscal Q2 2026 (2026-04-01 to 2026-06-30, 3mo).
XBRL companyfacts · 0000927066-26-000062Operating income rose from 481,892,000 USD in the fiscal Q1 2026 (2026-01-01 to 2026-03-31, 3mo) to 579,001,000 USD in the fiscal Q2 2026 (2026-04-01 to 2026-06-30, 3mo), implying an operating margin of ~14.1% in fiscal Q1 2026 (481,892,000 / 3,415,548,000) and ~16.3% in fiscal Q2 2026 (579,001,000 / 3,554,084,000).
XBRL companyfacts · 0000927066-26-000108Reads the filings themselves, above all the year-over-year diff of Item 1A risk factors: which risks a company added, dropped or quietly reworded since its last annual report.
Nothing in this slice of the evidence rose to a claim — a quiet read, which itself is information.
Which filings the desk reads
The desk reads the annual 10-K in full — its risk factors, and how they changed since last year. Quarterly 10-Qs and event filings (8-Ks, insider Form 4s) are listed for context but not read line by line: the 10-K is where the material risk disclosures live. A brand-new company, or one we have only just begun tracking, may have no annual report on file yet — its risk analysis fills in once that lands.
Reads the signal panel above — momentum, volatility, drawdown, relative strength and beta — and ranks each against the whole research universe rather than judging it in isolation.
No computed signal history for this symbol yet — signals need roughly 70 trading days of price history.
Reads which funds hold the name and at what weight, plus insider Form 4 filings, to show the exposure you may already carry through index funds.
As of 2026-09-02 13:45:47.228469+00:00, DVA appears as a holding in the IVV ETF with a weight of 0.01% of the fund.
ETF constituents · market dataMembership in IVV (the iShares Core S&P 500 ETF) is factual exposure context showing DVA is included in at least one major index fund as of 2026-09-02 13:45:47.228469+00:00.
ETF constituents · market dataReads recent headlines that are genuinely about this company, ignoring rating chatter and market-wide stories. Findings argue in the debate but never move the sentiment score.
A kalkinemedia headline published 2026-09-02 asked whether the Humana deal is "unlocking more value," focusing coverage on DaVita's deal-related prospects.
News · kalkinemedia.com · 2026-09-02A simplywall.st headline published 2026-09-02 reported that DaVita expanded a value-based care agreement with Humana to manage Medicare Advantage members with earlier-stage chronic kidney disease, framing the story as company-specific partnership news.
News · simplywall.st · 2026-09-02Reads parsed Forms 3/4/5 — who bought or sold, at what size, and whether a 10b5-1 plan was involved. Flags clustered open-market officer buying; treats plan sales as routine and never counts a fund or 10%-holder as an officer.
No insider transactions on file in the trailing 180 days.
Reads the implied-expectations math built from the company's own filings (the growth rate today's price would justify, and the multiples beside it) and argues whether the market's bar looks high or low for this business. Never turns the math into a target.
The model implies an FCF growth rate of 25.18% (0.2518) that today's price would justify under the stated discount and terminal assumptions.
Valuation inputs · SEC XBRL + stored EOD closePrice-to-free-cash-flow (P/FCF) is 37.69 based on trailing twelve-month FCF, and the stock price is 179.39 as of 2026-09-02.
Valuation inputs · SEC XBRL + stored EOD closeDebate and risk review
A bull and a bear contest the claims and the chair rules on each; the risk review stress-tests what survived.
A bull and a bear argue the analysts' claims across two rounds, then a chair rules on each one. Only what survives feeds the score — the argument is shown, not hidden, so you can judge the reasoning yourself.
Company-filed results show sequential revenue growth across the two most recent quarters, expanding operating income and rising net income, with operating margin increasing from ~14.1% to ~16.3% — all drawn from 10-Q/10-K filings. Reported large share repurchases and a meaningful reduction in reported common shares outstanding are consistent with capital return activity disclosed in filings, while cash and cash equivalents have remained roughly stable quarter-to-quarter. Market-context items (inclusion in IVV, multiple institutional purchases) and company-specific partnership headlines (expanded Humana value-based arrangement) provide additional supportive context from public reporting and media. These claims are supported by regulatory filings and recent media/institutional-disclosure sources, giving moderate-to-strong evidentiary weight to the operational and capital-allocation observations.
Chair's verdict, claim by claim
Fragility · computed, not argued
balanced0.32
21 surviving claims rest on 12 distinct sources; the heaviest analyst carries 33% of them, and 98% of what the desk raised survived the debate.
The read rests on a moderate breadth of sources but a relatively small set of analysts; one analyst supplies a third of surviving claims and nearly all initial desk points survived internal debate. That structure raises susceptibility to single-analyst bias and source-concentration: the findings are informative but should be weighted with caution because a few inputs carry outsized influence.
Disconfirming evidence · base rates · falsifiers
Context
Outside consensus, and where this name already sits in your own portfolio.
Third-party consensus shown for context. It never enters Moneyta sentiment — when the two diverge, the debate above is where the why lives.
What this was built from
Every figure on this page traces to one of these. The desk reads only what is listed here — no outside knowledge, no browsing — and each card shows who read it and what it contributed to the score.
13 filings· 2 cited
SEC XBRL filings
Quarterly figures as filed with the SEC, read straight from EDGAR's structured data — not retyped or estimated.
Read by Mercer+0.4 to the score
1 holdings record
Fund holdings
Which funds hold this name and at what weight, plus insider Form 4 filings.
Read by Ellis+0.0 to the score
8 headlines· 2 cited
News coverage
Recent headlines about this company, rating chatter excluded and nothing published after the report date.
Read by Yatesnothing survived
1 computation
Valuation inputs
TTM cash-flow figures from the company's own XBRL filings, priced with the stored closing price. Implied growth and multiples only; no fair-value dollar figure reaches the desk, by design.
Read by Archercontext only
1 record· 0 cited
Company profile
Sector, industry and company details.
Read means we pulled and handed it to an analyst; cited means a claim on this page points at it. Reading twelve quarters to state one trend is normal — the gap is shown rather than hidden.
Written by AI, checked against sources
The analysts, the bull–bear debate and the editor's note are AI agents reading only the evidence listed on this page. They can misread a filing or a headline, which is why every claim cites a source you can open and check yourself. The sentiment score is arithmetic over the claims that survived the debate, not a language model's opinion.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations. Past patterns do not indicate future results.
Get this for the tickers you actually hold
Plus the one thing no sample can show: how each name correlates with your portfolio, and what hides inside your funds.
The full terminal on DVA Gold
Who holds it, who's buying, what the Street thinks: live behind the lock, updated as filings land.
Institutional holders
Net institutional flow, Q/Q
Largest holder position
Insider buys, 90 days
Clustered insider value
Street target range
The real figures are for members. Educational analysis, not advice.
Educational analysis of published data. Moneyta does not give investment advice or make recommendations.